DARE - Dare Bioscience, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
2.06 0.0 (0.0%) --- --- --- 0.0 (0.0%) 0.0 (0.0%) --- 0.0 (0.0%)

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.45
Diluted EPS:
-0.45
Basic P/E:
-4.5778
Diluted P/E:
-4.5778
RSI(14) 1m:
49.66
VWAP:
2.06
RVol:
0.8745

Events

Period Kind Movement Occurred At
1m Price decrease 1m 2.05 -0.03 (-1.44%) Oct 15 12:38
1m Price increase 1m 2.1 +0.04 (+1.94%) Oct 15 11:46
1m Price increase 1m 2.09 +0.03 (+1.42%) Oct 15 09:48

Related News